09.24.25 -- Biotech Product Partnership: Novel Dual-Mechanism Immunotherapy

Embrace the power of a unified electronic clinical outcome assessment (eCOA) and Interactive Response Technology (IRT) platform to drive smarter decisions, ensure data accuracy, and boost efficiency.

Gain valuable takeaways from the PDA Ireland GDP event, covering essential insights on supply chain challenges, regulatory expectations, and the role of future technologies in pharmaceutical distribution.

Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.

Combining Functional Design of Experiments (Functional DOE) with traditional DOE methods enhances biopharmaceutical process optimization by capturing dynamic, time-based variations in cell culture systems.

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.